levodopa has been researched along with Diabetes Mellitus in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (66.67) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, MP; Nag, TC; Sen, S; Upreti, S | 1 |
| Ha, KS; Jeon, HY; Kim, M; Lee, AJ; Lee, YJ | 1 |
| Wubben, TJ | 1 |
| Koya Kutty, S; Mohamed Ibrahim, N; Ramli, R; Shah, SA | 1 |
| Abe, T; Fujita, K; Harada, M; Izumi, Y; Kaji, R; Osaki, Y | 1 |
| Agrawal, JK; Kumar, V; Raman, RD; Singh, R | 1 |
| Graczykowska-Koczorowska, A; Ponikowska, I | 1 |
| Duque, R; García Báez, M; González Espinosa, C; González, C; Lopes, S; Rodríguez, I | 1 |
| Ahlskog, JE; Kokmen, E; Low, PA; Nickander, KK; Petersen, RC; Tyce, GM; Uitti, RJ | 1 |
| Karlsen, K; Larsen, JP; Tandberg, E | 1 |
| Hickey, MA; Morton, AJ; Reynolds, GP | 1 |
| Cohen, KL | 1 |
| Babakhanov, KhB | 1 |
| Chez, RA; Epstein, M; Mintz, DH; Oakes, GK | 1 |
| Hansen, AP; Lundbaek, K | 1 |
| Kalinsky, HJ; Maragoudakis, ME; Wasvary, J | 1 |
| Jurcovicova, J; Klimes, I; Kolesar, P; Repcekova-Jezova, D; Vigas, M | 1 |
| Dobrew, D; Milanow, S; Zonew, I | 1 |
| Jurcovicová, J; Klimes, I; Kolesár, P; Repceková, D; Vigas, M | 1 |
| Campisi, R; Carducci Artenisio, A; Consolo, F; Forte, F; Martelli, G; Ragonese, F | 1 |
| Barbarino, A; De Marinis, L; Martino, F | 1 |
| Christensen, SE; Hansen, AP; Lundbaek, K | 1 |
| Ajlouni, K; Hagen, TC; Martinson, DR | 1 |
| Ieiri, T; Kasai, K; Kikuchi, T; Shimoda, S; Takemura, Y | 1 |
2 review(s) available for levodopa and Diabetes Mellitus
| Article | Year |
|---|---|
Metabolic, endocrine, and drug-induced interference with pituitary function tests: a review.
Topics: Anorexia; Antipsychotic Agents; Depression; Diabetes Mellitus; Drug-Related Side Effects and Adverse Reactions; Endocrine System Diseases; Ethanol; Hormones; Humans; Hypokalemia; Levodopa; Liver Cirrhosis; Metabolic Diseases; Morphine; Obesity; Phenothiazines; Pituitary Function Tests; Pituitary Gland; Starvation; Uremia | 1977 |
Somatostatin: a review of its effects especially in human beings.
Topics: Acromegaly; Adenoma, Islet Cell; Animals; Arginine; Blood Glucose; Diabetes Mellitus; Dogs; Glucagon; Growth Hormone; Humans; Hydroxybutyrates; Hypothalamus; Insulin; Ketone Bodies; Levodopa; Pancreas; Pituitary Hormones, Anterior; Somatostatin | 1976 |
22 other study(ies) available for levodopa and Diabetes Mellitus
| Article | Year |
|---|---|
Insulin like growth factor-1 works synergistically with dopamine to attenuate diabetic retinopathy by downregulating vascular endothelial growth factor.
Topics: Animals; Diabetes Mellitus; Diabetic Retinopathy; Dopamine; Endothelial Cells; Insulin-Like Growth Factor I; Levodopa; Rats; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2022 |
Dopamine ameliorates hyperglycemic memory-induced microvascular dysfunction in diabetic retinopathy.
Topics: Animals; Diabetes Mellitus; Diabetic Retinopathy; Dopamine; Endothelial Cells; Humans; Levodopa; Mice; Retina; Retinal Vessels | 2022 |
Dopamine and Early Retinal Dysfunction in Diabetes: Insights From a Phase 1 Study.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Dopamine; Electroretinography; Humans; Levodopa; Retina | 2020 |
Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus.
Topics: Aged; Antiparkinson Agents; Diabetes Complications; Diabetes Mellitus; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Parkinsonian Disorders | 2018 |
Mystery Case: Parkinsonism in a diabetic uremic patient.
Topics: Aged; Antiparkinson Agents; Basal Ganglia; Diabetes Mellitus; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Renal Dialysis; Steroids | 2016 |
Growth hormone and diabetic retinopathy.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Fasting; Growth Hormone; Humans; Levodopa; Middle Aged; Stimulation, Chemical | 1983 |
[Blood serum growth hormone and insulin concentration in persons with normal body weight, obese patients without carbohydrate intolerance and obese diabetics after L-dopa loading test].
Topics: Adult; Body Weight; Diabetes Mellitus; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Levodopa; Male; Obesity | 1980 |
[A dynamic study of HGH, zinc and copper in diabetic girls. Preliminary report].
Topics: Adolescent; Arginine; Blood Glucose; Child; Child, Preschool; Copper; Diabetes Mellitus; Female; Humans; Levodopa; Somatomedins; Zinc | 1982 |
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Brain; Cabergoline; Carbidopa; Diabetes Mellitus; Ergolines; Female; Free Radicals; Humans; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Selegiline; Vitamin E | 1995 |
Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.
Topics: Age of Onset; Aged; Antiparkinson Agents; Case-Control Studies; Dementia; Depression; Diabetes Mellitus; Drug Tolerance; Fatigue; Female; Humans; Levodopa; Male; Movement Disorders; Neurologic Examination; Norway; Outpatients; Parkinson Disease; Prevalence; Psychomotor Performance; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires | 2000 |
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.
Topics: Aging; Animals; Behavior, Animal; Brain; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Huntington Disease; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Spatial Behavior; Survival Rate | 2002 |
[Method of determination of somatotropin level in blood plasma with L-dopa loading in patients with diabetes mellitus complicated by microangiopathies].
Topics: Adolescent; Adult; Aged; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Radioimmunoassay | 1975 |
Fetal pancreatic glucagon responses in glucose-intolerant nonhuman primate pregnancy.
Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Haplorhini; Levodopa; Macaca mulatta; Pancreas; Pregnancy; Pregnancy in Diabetics; Streptozocin | 1977 |
Effects of L-dopa, GPA 1734 and other agents on basement membrane biosynthesis.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Basement Membrane; Collagen; Diabetes Mellitus; Female; Hormones; In Vitro Techniques; Levodopa; Microtubules; Pregnancy; Procollagen-Proline Dioxygenase; Prostaglandins; Quinolizines; Rats; Skin | 1978 |
Inhibition of L-dopa induced growth hormone release in normal and diabetic subjects by glucose administration.
Topics: Adult; Diabetes Mellitus; Female; Glucose; Growth Hormone; Humans; Hyperglycemia; Levodopa; Male; Middle Aged | 1977 |
The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Diabetes Mellitus; Dihydroergotoxine; Drug Evaluation; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Pituitary Gland, Anterior; Secretory Rate | 1977 |
Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Levodopa; Male; Middle Aged | 1978 |
[Levodopa and somatotropic hormone in diabetes].
Topics: Diabetes Mellitus; Growth Hormone; Humans; Levodopa; Middle Aged; Pituitary Gland, Anterior; Stimulation, Chemical | 1978 |
Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.
Topics: Adolescent; Adult; Aged; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Growth Hormone; Humans; Hyperglycemia; Levodopa; Male; Middle Aged | 1978 |
The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
Topics: Arginine; Blood Glucose; Depression, Chemical; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Levodopa; Somatostatin; Stimulation, Chemical | 1975 |
Effect of glucose on the growth hormone response to L-dopa in normal and diabetic subjects.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Glucose; Growth Hormone; Humans; Hyperglycemia; Hypothalamus; Levodopa; Male; Pituitary Gland | 1975 |
[A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
Topics: Adult; Antigens; Arginine; Blood Glucose; Diabetes Mellitus; Glucose Tolerance Test; Growth Hormone; Humans; Hyperthyroidism; Injections, Intravenous; Insulin; Levodopa; Middle Aged; Time Factors; Tolbutamide | 1975 |